Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.67 |
| ▸ | CDC7 | O00311 | 1/20 | 0.59 |
| ▸ | DYRK3 | O43781 | 1/20 | 0.59 |
| ▸ | IGF1R | P08069 | 1/20 | 0.59 |
| ▸ | PIM1 | P11309 | 1/20 | 0.59 |
| ▸ | CLK2 | P49760 | 1/20 | 0.59 |
| ▸ | GSK3A | P49840 | 1/20 | 0.59 |
| ▸ | GSK3B | P49841 | 1/20 | 0.59 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.59 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.59 |
| ▸ | PKN2 | Q16513 | 1/20 | 0.59 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.59 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.59 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.59 |
| ▸ | HRH4 | Q9H3N8 | 14/20 | 0.58 |
| ▸ | AHR | P35869 | 3/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31695336 | 0.85 | ALDH1A1 (0.73) | ALDH1A1LMNAKMT2AGPR55SMN1; SMN2 | |
| SCHEMBL18496512 | 0.83 | ALDH1A1 (0.71) | ALDH1A1LMNAKMT2AGPR55SMN1; SMN2 | |
| SCHEMBL4594004 | 0.83 | ALDH1A1 (0.71) | ALDH1A1LMNAKMT2AGPR55SMN1; SMN2 | |
| SCHEMBL29989707 | 0.80 | SMN1; SMN2 (1.00) | ALDH1A1LMNAKMT2AGPR55SMN1; SMN2 | |
| SCHEMBL4539658 | 0.80 | SMN1; SMN2 (1.00) | ALDH1A1LMNAKMT2AGPR55SMN1; SMN2 | |
| SCHEMBL2494411 | 0.79 | KMT2A (0.66) | ALDH1A1LMNAKMT2AGPR55CDC7 | |
| SCHEMBL30117918 | 0.79 | KMT2A (0.66) | ALDH1A1LMNAKMT2AGPR55CDC7 | |
| SCHEMBL23610616 | 0.79 | SMN1; SMN2 (0.67) | ALDH1A1LMNAKMT2AGPR55SMN1; SMN2 | |
| SCHEMBL4593656 | 0.79 | ALDH1A1 (0.65) | ALDH1A1LMNAKMT2AGPR55SMN1; SMN2 | |
| SCHEMBL27164742 | 0.78 | SMN1; SMN2 (0.74) | ALDH1A1LMNAKMT2AGPR55SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250313568-A1 | Organic Compound, Mixture Thereof, And Method For Synthesizing Organic Compound | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2025-10-09 | — | — | US | disclosed |
| US-20250204248-A1 | Organic Compound And Light-Emitting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2025-06-19 | — | — | US | disclosed |
| CN-120157700-A | Organic compound and light-emitting device | 株式会社半导体能源研究所 | 2025-06-17 | — | — | CN | disclosed |
| US-20240373748-A1 | Organic Compound, Light-Emitting Device, Light-Emitting Apparatus, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2024-11-07 | — | — | US | disclosed |
| US-12043624-B2 | Organic compound, light-emitting element, light-emitting device, electronic device, and lighting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2024-07-23 | — | — | US | disclosed |
| US-12043624-B2 | Organic compound, light-emitting element, light-emitting device, electronic device, and lighting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2024-07-23 | — | — | US | disclosed |
| US-12043624-B2 | Organic compound, light-emitting element, light-emitting device, electronic device, and lighting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2024-07-23 | — | — | US | disclosed |
| US-12029118-B2 | Organic compound, light-emitting device, light-emitting apparatus, electronic device and lighting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2024-07-02 | — | — | US | disclosed |
| US-12029118-B2 | Organic compound, light-emitting device, light-emitting apparatus, electronic device and lighting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2024-07-02 | — | — | US | disclosed |
| US-12029118-B2 | Organic compound, light-emitting device, light-emitting apparatus, electronic device and lighting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2024-07-02 | — | — | US | disclosed |
| US-20080261946-A1 | Pyrimidine Compounds for the Treatment of Inflammatory Disorders | CELLZOME (UK) LTD. (GB) | 2008-10-23 | — | — | US | disclosed |
| EP-1945646-A1 | PYRIMIDINE COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS | Cellzome (UK) Ltd. (GB) | 2008-07-23 | — | — | EP | disclosed |
| EP-1812113-A1 | PYRIMIDINE COMPOUNDS AS HISTAMINE MODULATORS | Argenta Discovery Limited (GB) | 2007-08-01 | — | — | EP | disclosed |
| EP-1776982-A1 | Pyrimidine compounds as histamine modulators | Argenta Discovery Limited (GB) | 2007-04-25 | — | — | EP | disclosed |
| EP-1776982-A1 | Pyrimidine compounds as histamine modulators | Argenta Discovery Limited (GB) | 2007-04-25 | — | — | EP | disclosed |
| WO-2007039467-A1 | PYRIMIDINE COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS | CELLZOME (UK) LTD. (GB) | 2007-04-12 | — | — | WO | disclosed |
| WO-2007039467-A1 | PYRIMIDINE COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS | CELLZOME (UK) LTD. (GB) | 2007-04-12 | — | — | WO | disclosed |
| EP-1767537-A1 | Pyrimidine compounds for the treatment of inflammatory disorders | Cellzome (UK) Ltd. (GB) | 2007-03-28 | — | — | EP | disclosed |
| EP-1767537-A1 | Pyrimidine compounds for the treatment of inflammatory disorders | Cellzome (UK) Ltd. (GB) | 2007-03-28 | — | — | EP | disclosed |
| WO-2006050965-A1 | PYRIMIDINE COMPOUNDS AS HISTAMINE MODULATORS | ARGENTA DISCOVERY LTD (GB) | 2006-05-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12043624-B2 | Organic compound, light-emitting element, light-emitting device, electronic device, and lighting device | CCNE2, NFE2L2, AOX1 | ALDH1A1 134/4885LMNA 3438/4885KMT2A 1223/4885 |
| US-12029118-B2 | Organic compound, light-emitting device, light-emitting apparatus, electronic device and lighting device | TPMT, CYP1A1, CYP1B1 | ALDH1A1 31/4885LMNA 2796/4885KMT2A 1994/4885 |
| US-20080261946-A1 | Pyrimidine Compounds for the Treatment of Inflammatory Disorders | HRH4, HRH3, HRH2 | ALDH1A1 1823/4885LMNA 4565/4885KMT2A 1030/4885 |
| US-20250313568-A1 | Organic Compound, Mixture Thereof, And Method For Synthesizing Organic Compound | XDH, BMP4, ODC1 | ALDH1A1 3319/4885LMNA 3962/4885KMT2A 3749/4885 |
| US-20240373748-A1 | Organic Compound, Light-Emitting Device, Light-Emitting Apparatus, Electronic Device, and Lighting Device | TPMT, CYP1A1, CYP3A4 | ALDH1A1 34/4885LMNA 2910/4885KMT2A 2264/4885 |
| US-20250204248-A1 | Organic Compound And Light-Emitting Device | TPMT, PAICS, TYMS | ALDH1A1 557/4885LMNA 3924/4885KMT2A 2395/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.